
None of four cough syrups linked to death of 66 children in Gambia available for sale in India, say distributors
The HinduNone of the four cough syrups — Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup — being linked to the death of 66 children in the Gambia is available for sale in India, said the All India Organisation of Chemists and Distributors. “Maiden Pharmaceutical Limited has no presence in the Indian domestic market and they only export their products,’’ said Rajeev Singhal, general secretary, AIOCD. He said Indian distributors had been alerted on Thursday about the adverse effect of the drug “and have been cautioned against any possible availability or distribution of these in any part of the country.’’ WHO had mentioned that all the four ‘contaminated’ medicines manufactured by Maiden Pharmaceuticals Ltd may have been distributed elsewhere through informal markets but it had only been identified in the Gambia. Pawan Kumar, paediatrician, Madhukar Rainbow Children’s Hospital, said diethylene glycol is used as an illegal adulterant in medications and can result in renal and neurological toxicity.
History of this topic

Over 100 Indian cough syrups have toxins linked to Gambia, Uzbek-deaths: Report
Live Mint
India bans anti-cold drug combination for infants
Live Mint
Vantage | Why poor quality cough syrups may poison India's reputation too
Firstpost
India finds 2 more toxic cough syrups: What we know about them
Firstpost
Whatever happened to the case of 66 child deaths linked to cough syrup from India?
NPR
‘Indian cough syrup sent to Iraq contains toxic chemicals’, test shows
Live Mint
India’s pharma export surges despite cough syrup deaths: Report
Live Mint
The lowdown on ‘substandard’ cough syrups
The Hindu
No tolerance on spurious meds, 71 firms issued notices: Mandaviya on cough syrup row
Deccan Chronicle
Safety first: on Indian pharma products and drug safety
The Hindu
Test cough syrups meant for exports on priority: DCGI
Hindustan Times
India considers policy change after cough syrup deaths: PM Modi's office
The Hindu
Indian cough syrup: mystery middleman may be new clue
The Hindu
WHO issues alert for another India-made cough syrup: Why are these drugs so deadly?
Firstpost
Guaifenesin: WHO flags India-made ‘contaminated’ cough syrup with ‘unacceptable amounts’ of toxic chemicals
The Independent
Contaminated syrups manufactured in India reported in WHO’s Western Pacific region
The Hindu
18 pharma companies lose licence over poor quality drugs
The Hindu
Cough Syrup Deaths in Gambia, Uzbekistan: 18 Indian Drug Makers Lose Licence in Big Clean-Up
News 18
Uzbekistan cough syrup deaths| Marion Biotech’s licence cancelled
The Hindu
Cough Syrup Deaths: DCGI Directs Drug Manufacturers Not to Use Propylene Glycol Supplied by Delhi Firm
News 18
Uzbek cough syrup deaths: DCGI issues alert against supplier of Marion Biotech
Hindustan Times
Licences of six cough syrup makers in Maharashtra suspended for violation of rules
The Hindu
Cough Syrup Death Cases: US CDC Blames Indian Pharma Firm for Demise of Gambia Kids; 3 Held in Noida Over Uzbekistan Incident
News 18
U.S.-CDC probe into cough syrup deaths in The Gambia pins blame on Indian manufacturer
The Hindu
Cough Syrup Row: Maharashtra Govt Acted against 27 Pharma Firms, Says Minister
News 18
WHO calls for action to protect children from contaminated medicines after cough syrups deaths
The Hindu
WHO urges 'immediate action' after 300 children die due to cough syrup
Firstpost
Cough Syrup deaths: WHO investigating links between manufacturers in India
Live Mint
WHO calls for action to protect children from contaminated medicines after cough syrups deaths
India TV News
WHO Urges 'Immediate and Coordinated Action' on Contaminated Medicines After Child Deaths
News 18
Indonesia court hearing into children killed by toxic cough syrup
Al Jazeera
Uzbekistan, Gambia Cough Syrup Cases: 'Concerned' Commerce Ministry Advises Thorough Probe - News18
News 18
Behind the Indian cough syrup that killed many in Gambia and Uzbekistan
The Hindu
'Substandard...': WHO warns against use of cough syrups linked to Uzbek deaths
Hindustan Times
India cough syrup linked to Uzbekistan deaths ‘substandard’: WHO
Al Jazeera
Indian cough syrups should not be used for kids in Uzbekistan: WHO
Live Mint
At the precipice of shame: The Hindu Editorial on The Gambia and Uzbekistan cough syrup deaths
The Hindu
Indian maker of cough syrup linked to Uzbekistan deaths halts production
The Independent
Noida firm stops syrup blamed for 11 kid deaths
Deccan Chronicle
BJP, Cong spar over cough syrup related deaths in Uzbekistan, Gambia
Deccan Chronicle
Marion Biotech: The Noida-based pharma company at the centre of the Uzbekistan cough syrup tragedy
Firstpost
India seeks details of Uzbekistan’s investigation into cough syrup
Hindustan Times
Congress, BJP trade barbs over cough syrup-related deaths of children in Uzbekistan and Gambia
The Hindu
Uzbekistan links deaths of at least 18 children to India-made syrup
The Independent
Cough syrup deaths | India seeks details from Uzbekistan on investigations
The Hindu
Indian pharma under scrutiny again after 18 Uzbek child deaths
Al Jazeera
Another Gambia-type situation? Did 18 children in Uzbekistan die after consuming cough syrup made in India?
Firstpost
18 children dead due to cough syrup made by Indian firm, says Uzbekistan
The Hindu
Uzbekistan says 18 children die after consuming India-made syrup
Al Jazeera
Gambia parliament recommends suing of Indian manufacturer of cough syrups
The IndependentDiscover Related






































